NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

ADLINE CHEM LAB : Q1 2024 Financial Quarterly Report

July 19, 2024July 19, 2024| adminadmin| 0 Comments| 5:25 pm
Image is loading
Categories:

Share the post "ADLINE CHEM LAB : Q1 2024 Financial Quarterly Report"

  • Facebook
  • LinkedIn
  • X
  • Tumblr
  • WhatsApp
  • TelegramTelegram
  • Email

Highlights

  • Sales over the Year and quarter:
  • Income over the Year and quarter:
  • Profit over the Year and quarter: Significant improvement in profitability for ADLINE CHEM LAB LIMITED. Notable increase of 23.17 % in net profit Year to Year, ADLINE CHEM LAB LIMITED’s profitability increased by 180.56 % in this quarter.
  • EPS over the Year and quarter: EPS increased by 21.43 % Year to Year. EPS decreased by -383.33 % in previous quarter. Analysis needed for shareholder value.

The comprehensive analytics outlining the performance and outlook of ADLINE CHEM LAB LIMITED”s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 0 Cr Rs. 0 Cr Rs. 0 Cr 0 % 0 %
Expenses Rs. 0.08 Cr Rs. 0.06 Cr Rs. 0.1 Cr + 66.67 % + 25 %
Operating Profit Rs. -0.08 Cr Rs. -0.06 Cr Rs. -0.1 Cr -66.67 % -25 %
OPM % 0 % 0 % 0 % 0 % 0 %
Other Income Rs. 0 Cr Rs. 0.02 Cr Rs. 0 Cr 0 % 0 %
Interest Rs. 0 Cr Rs. 0 Cr Rs. 0 Cr 0 % 0 %
Depreciation Rs. 0 Cr Rs. 0 Cr Rs. 0 Cr 0 % 0 %
Profit before tax Rs. -0.08 Cr Rs. -0.04 Cr Rs. -0.1 Cr -150 % -25 %
Tax % -0 % -0 % -0 % 0 % 0 %
Net Profit Rs. -0.08 Cr Rs. -0.04 Cr Rs. -0.1 Cr -150 % -25 %
EPS in Rs Rs. -0.14 Rs. -0.06 Rs. -0.17 -183.33 % -21.43 %


Today, we’re looking at ADLINE CHEM LAB LIMITED’s financial performance for the Q1(Jun 2024).Expenses ticked up slightly by 66.67 % quarter-on-quarter, aligning with the annual rise of 25 %. Operating profit, while down -25 % compared to last year, faced a quarter-on-quarter dip of -66.67 %, signaling a short-term contraction in margins.
Profit before tax declined annually by -25 % but saw a reduction from the preceding quarter by -150 %.
Net profit fell by -25 % year-on-year but witnessed a -150 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -21.43 % but a quarterly fall of -183.33 %. In summary, ADLINE CHEM LAB LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 0 Cr Rs. 0 Cr Rs. 0 Cr 0 % 0 %
Expenses Rs. 0.08 Cr Rs. 0.06 Cr Rs. 0.1 Cr + 66.67 % + 25 %
Operating Profit Rs. -0.08 Cr Rs. -0.06 Cr Rs. -0.1 Cr -66.67 % -25 %
Net Profit Rs. -0.08 Cr Rs. -0.04 Cr Rs. -0.1 Cr -150 % -25 %
EPS in Rs Rs. -0.14 Rs. -0.06 Rs. -0.17 -183.33 % -21.43 %


In reviewing ADLINE CHEM LAB LIMITED’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Expenses rose by 25 % compared to the previous year, with a 66.67 % increase quarter-on-quarter. Operating Profit dropped by -25 % annually, and saw a -66.67 % decrease from the last quarter.
Net Profit showed yearly decrease of -25 %, and experienced a -150 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -21.43 % annually, however dipped by -183.33 % compared to the last quarter. In essence, while ADLINE CHEM LAB LIMITED faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.

[my_shortcode1 values=”Spencer”]

Related Post